ClearPoint Neuro, Inc.
CLPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 31% | 16.6% | 26.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.9% | 56.8% | 65.8% | 68.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -56.8% | -87.6% | -75.8% | -78.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -60.3% | -92.2% | -80% | -88.4% |
| EPS Diluted | -0.7 | -0.9 | -0.68 | -0.69 |
| % Growth | 22.2% | -32.4% | 1.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |